RT Journal Article
SR Electronic
T1 NIAGADS: A Comprehensive National Data Repository for Alzheimer’s Disease and Related Dementia Genetics and Genomics Research
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.10.07.24315029
DO 10.1101/2024.10.07.24315029
A1 Kuzma, Amanda
A1 Valladares, Otto
A1 Greenfest-Allen, Emily
A1 Nicaretta, Heather
A1 Kirsch, Maureen
A1 Ren, Youli
A1 Katanic, Zivadin
A1 White, Heather
A1 Wilk, Andrew
A1 Bass, Lauren
A1 Brettschneider, Jascha
A1 Carter, Luke
A1 Cifello, Jeffrey
A1 Chuang, Wei-Hsuan
A1 Clark, Kaylyn
A1 Gangadharan, Prabhakaran
A1 Haut, Jacob
A1 Ho, Pei-Chuan
A1 Horng, Wenhwai
A1 Iqbal, Taha
A1 Jin, Yumi
A1 Keskinen, Peter
A1 Rose, Alexis Lerro
A1 Moon, Michelle K
A1 Manuel, Joseph
A1 Qu, Liming
A1 Robbins, Flawless
A1 Saravanan, Naveensri
A1 Sha, Jin
A1 Tate, Sam
A1 Zhao, Yi
A1 Alzheimer’s Disease Sequencing Project
A1 Cantwell, Laura
A1 Gardner, Jake
A1 Chou, Shin-Yi
A1 Tzeng, Jung-Ying
A1 Bush, William
A1 Naj, Adam
A1 Kuksa, Pavel
A1 Lee, Wan-Ping
A1 Leung, Yuk Yee
A1 Schellenberg, Gerard
A1 Wang, Li-San
YR 2024
UL http://medrxiv.org/content/early/2024/12/07/2024.10.07.24315029.abstract
AB NIAGADS is the National Institute on Aging (NIA) designated national data repository for human genetics research on Alzheimer’s Disease and related dementia (ADRD). NIAGADS maintains a high-quality data collection for ADRD genetic/genomic research and supports genetics data production and analysis. NIAGADS hosts whole genome and exome sequence data from the Alzheimer’s Disease Sequencing Project (ADSP) and other genotype/phenotype data, encompassing 209,000 samples. NIAGADS shares these data with hundreds of research groups around the world via the Data Sharing Service, a FISMA moderate compliant cloud- based platform that fully supports the NIH Genome Data Sharing Policy. NIAGADS Open Access consists of multiple knowledge bases with genome-wide association summary statistics and rich annotations on the biological significance of genetic variants and genes across the human genome. NIAGADS stands as a keystone in promoting collaborations to advance the understanding and treatment of Alzheimer’s disease.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNIAGADS is supported by an NIH/NIA collaborative agreement (U24-AG041689).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Yes